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AbstrAct
Introduction: Pain is a common symptom in 
patients with autosomal dominant polycys-
tic kidney disease (ADPKD), affecting 
around 60% of cases. Objective: Translate 
a pain questionnaire developed and valida-
ted for ADPKD in USA into Portuguese and 
to perform its cultural adaptation and apply 
it. Method: The cultural adaptation perfor-
med by a panel of experts resulted in small 
changes consisting of words substitution 
by synonyms or deletion of terms not com-
monly used in our culture in 12 out of the 
46 questions posed, to solve patients diffi-
culties in understanding the questionnaire. 
Results: There has been equivalence betwe-
en the adapted form of the instrument with 
the back-translation. The final form of the 
questionnaire applied in 97 patients with 
ADPKD (64F/33M, 35 ± 12 years) showed 
that 65 (67%) had isolated or associated 
pain in multiple locations , more often at 
lumbar region (77%), followed by abdomi-
nal (66%), headache (15%) and chest (4%). 
The questionnaire revealed that after family 
history, pain was the second factor contri-
buting to the diagnosis of ADPKD in this 
population (55% and 22% of cases, respec-
tively). Discussion: Clinical and laboratory 
data from medical records showed that pa-
tients referring pain had renal volume and 
size of the largest cyst significantly higher 
than those without pain. Conclusion: We 
conclude that the use of a specific pain ques-
tionnaire for ADPKD population provided a 
better characterization of this symptom, as 
well as its relationship with the associated 
complications that commonly occur in this 
setting.
Keywords: polycystic kidney diseases, pain 
measurement, low back pain.
[J Bras Nefrol 2010;32(4): 386-399]©Elsevier Editora Ltda.
Translation, cultural adaptation and aplication of a pain 
questionnaire for patients with polycystic kidney disease
IntroductIon
Autosomal dominant polycystic kidney 
disease (ADPKD), characterized by the 
progressive development of bilateral renal 
cysts, has an incidence ranging from 1:400 
to 1:1000 live births. It accounts for up to 
10% of the patients with end-stage renal 
disease (ESRD) undergoing renal repla-
cement therapy (dialysis or transplanta-
tion).1,2 In ADPKD, cysts may be found in 
other organs, such as the spleen, pancreas, 
and, most commonly, the liver.2,3 In addi-
tion, other extra-renal manifestations, su-
ch as abdominal wall hernias, diverticu-
litis, valvular abnormalities, and cerebral 
aneurysms, can be found.4,5 Among the 
renal manifestations of ADPKD, the follo-
wing are the most common: arterial hyper-
tension; urinary infection; nephrolithiasis; 
low back pain; hematuria; increased kid-
ney volume; and progressive loss of renal 
function.6 Arterial hypertension is an ear-
ly and frequent complication of ADPKD. 
It affects 60% of the patients, even before 
renal function impairment, probably due 
to stimulation of the renin-angiotensin-
-aldosterone system caused by the growth 
of the cysts.7 Hematuria can result from 
the rupture of cysts8 or from the presence 
of kidney stones that are very frequent in 
ADPKD due to anatomical and/or meta-
bolic abnormalities.9,10,11 Urinary tract in-
fection (UTI) and infection of the cysts are 
also frequent in ADPKD.12 End-stage re-
nal disease, which occurs in almost 50% 
of the patients with ADPKD until the 
sixth decade of life,5 results from the re-
duction in the renal parenchyma replaced 
by the cysts, and from vascular sclerosis 
and interstitial fibrosis.1,2 The diagnosis 
of ADCKD can be suspected from the in-
vestigation of the family history or of the 
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innumerous conditions associated. Ultrasonography 
is the most used imaging test for the diagnosis of 
ADPKD, and has a sensitivity close to 100% for indi-
viduals over the age of 30 years suspected of having 
ADPKD;13 for younger individuals, nuclear magnetic 
resonance is the method of choice.14
Although ADPKD usually remains asymptomatic 
for many years, pain is a common symptom, and can 
even affect 60% of the adult population with that di-
sease.15 Bajwa et al16 have reported the following most 
frequent locations of pain in that population: low ba-
ck; abdomen; chest; lower limbs; and head. The low 
back and/or abdominal pain in patients with ADPKD 
is multifactorial. It can occur acutely due to cyst ruptu-
re or infection, kidney stone elimination, and UTI, or 
can be chronic resulting from increased kidney or liver 
volume, due to cyst expansion,6 or even from diverti-
culitis. As the cysts are associated with excessive an-
giogenesis, polycystic kidneys are specially susceptible 
to traumas, which can lead to hemorrhage or bleeding 
in the retroperitoneal space, usually accompanied by 
intense pain.17 Intracystic hemorrhages occur usually 
in 90% of ADPKD patients and are characterized by 
the presence of  hyperdense cysts on imaging tests.18 
Some patients do not associate the pain with the cysts, 
and, thus, the episodes of cystic hemorrhage can pass 
undiagnosed when gross hematuria is absent.18 The 
headache of ADPKD patients can be related to the 
presence of cerebral aneurysms, but the frequency of 
headache does not differ from that of the general po-
pulation.19 Thus, that diversity of factors turns pain 
into a challenging diagnosis in such patients. The pain 
reported by ADPKD patients is usually treated with 
analgesics, but, when the pain is severe, special thera-
pies, such as transcutaneous stimulation, use of local 
anesthetics, or even open or laparoscopic surgery, may 
be required.20,21
The high percentage of ADPKD patients repor-
ting pain emphasizes the importance of a specific pain 
questionnaire that better characterizes that sympto-
matology, providing better assessment to determine 
more adequate therapeutic measures for each patient. 
The cost and complexity involved in the elaboration 
of a questionnaire can be minimized by the use of a 
translated questionnaire already validated in other 
countries.22 However, transcultural adaptation of such 
questionnaires is required for their use in each coun-
try.23,24 The present study aimed at performing the 
Portuguese translation and transcultural adaptation of 
a pain questionnaire specific for ADPKD patients, de-
veloped and validated by Bajwa et al16 in 2004, and at 
its application in a sample of ADPKD patients.
PAtIents And methods
The pain questionnaire developed and validated by 
the group of Steinman for the North-American po-
pulation with ADPKD16 has 46 questions. It inclu-
ded since how and when the diagnosis of ADPKD 
was made to pain characteristics, such as location, 
frequency, intensity, and associated pathologies. 
The initial translation of the pain questionnaire in-
to Portuguese was performed by a nephrologist and 
revised by a multidisciplinary team (two physicians, 
one nurse, two biologists, and two nutritionists), ai-
ming at assessing the clarity and understanding of the 
questions. The differences found or expressions consi-
dered difficult to be understood by the lay population 
were replaced with a more simple language, in such a 
way not to change the conceptual translation of the 
question. Eventually, the version considered definitive 
underwent backtranslation by an independent trans-
lator, aiming at comparing the Portuguese translated 
and the English original versions.
SelectiOn Of patientS
One hundred adult patients, followed up at the 
Polycystic Kidney Outpatient Clinics of the Discipline 
of Nephrology of the Federal University of São Paulo 
(UNIFESP) were selected. The diagnosis of ADPKD 
was made based on the presence of a family history of 
the disease (an affected parent) and data obtained with 
kidney ultrasonography, meeting the criteria proposed 
by Pei13 for each age bracket. Data regarding kidney 
volume, number of cysts, and size of the largest cyst 
were obtained from the ultrasound reports on the me-
dical records. Kidney volume was determined by use of 
the formula of the modified ellipsoid = 4/3 π x (ante-
roposterior diameter/4 + width/4)2 x length/2,25 and, in 
the present study, it was considered as the sum of the 
volumes of both kidneys.26 
The initial contact with patients occurred during the 
pre-consultation at the Polycystic Kidney Outpatient 
Clinics, which consisted in measuring weight, height, 
and blood pressure (BP), and was followed by an infor-
mal approach for questioning about the volunteer par-
ticipation in the study. Patients with the pre-established 
diagnosis of arterial hypertension, or those undergoing 
medicamentous treatment and having a normal BP on 
the day of measurement have also been considered as 
hypertensives. Other clinical findings, such as presence 
of lithiasis, UTI, or hematuria, were obtained from the 
medical records. The renal function level was defined 
by determining creatinine clearance (CrCl) in blood and 
24-h urine, which was also extracted from the medical 
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records. Chronic kidney disease (CKD) stage 1 was de-
fined as kidney damage caused by the presence of cysts 
on imaging tests, and CrCl ≥ 90 mL/min/1.73m2. Stage 
2 was defined as the presence of kidney damage and 
CrCl between 60 and 89 mL/min/1.73m2; and stage 3 
was defined as CrCl below 60 mL/min/1.73m2.27
applicatiOn Of the queStiOnnaire
The questionnaire was applied to 97 patients out of 
the 100 previously selected, considered as having a 
good capacity of understanding. They had no pain 
at the time of questionnaire application to reduce the 
possibility of influencing their responses. Three pa-
tients refused to or could not participate in the study 
because they could not understand the questions pro-
posed. The questionnaire was individually applied at 
a private room, with no interference of a third party, 
for a mean time of 15 minutes. All patients included 
in the study were informed about the research and 
provided written informed consent. The study was ap-
proved by the Committee on Ethics of the UNIFESP.
Pain intensity was measured by use of the visual 
analogue scale (VAS),28 present in the original ques-
tionnaire16 and used in clinical practice and other stu-
dies. That scale comprises a score ranging from zero 
to ten, where zero corresponds to lack of pain and ten 
corresponds to maximum pain intensity.16
StatiStical analySiS
The numerical variables were expressed as medians 
(minimum value – maximum value), and the Mann-
Whitney test was used to compare the groups. The 
categorical variables were expressed as numbers and 
percentages, and the Chi-square test and Fisher exact 
test, when indicated, were used for comparisons. 
Non-parametric tests were used due to lack of nor-
mal distribution of the numerical variables between 
both groups. The significance level adopted for the 
statistical tests was 5% (p value < 0.05), and the sof-
tware used for the analyses was the SAS System for 
Windows (Statistical Analysis system), version 8.02.
results
tranSlatiOn and tranScultural adaptatiOn Of the 
queStiOnnaire
The initial translation from English to Portuguese was 
assessed by the multidisciplinary team. Some expres-
sions originally used required changes to be better un-
derstood by the patients. The first change was in the 
title of the questionnaire adopted in the English origi-
nal version: from “The questionnaire employed in the 
PKD population – headache and pain in polycystic 
kidney disease project” to “Questionnaire for patients 
with polycystic kidney disease”. As shown in Table 1, 
only some words present in 12 of the 46 questions re-
quired changes for adaptation to local culture. Those 
changes consisted basically in replacing some words 
or expressions by synonyms, or in including between 
parentheses terms to which no equivalent was found 
in Portuguese, aiming at enhancing understanding by 
the patients. For example, as shown in Table 1, in 
item D3, in the description of the type of chest pain, 
the term “undefined” was added between parentheses 
to the expression “aching”, to exclude all other adjec-
tives for defining that pain (stabbing, dull pressure, 
cramping, intermittent, and continuous). That change 
Table 1 MOdificatiOnS Of the deScriptOrS Of the Original queStiOnnaire SuggeSted by the MultidiSciplinary teaM 
Item of the questionnaire/ words Initial translation (Version 1) Modification (Version 2)
10/ Has your pain ever been 
associated with blood in your urine?
Alguma vez esta dor “associou-se” com 
sangue na urina?
Alguma vez esta dor foi 
acompanhada  de sangue na urina? 
A4/... Ice massage ... “Massagem fria” ... “Gelo”
A5/... Abdominal fullness? ... “Sensação de plenitude abdominal”? ... “sensação de estômago cheio”? 
D3/ Dull press Pressão “incômoda” Pressão “desagradável”
D3/Type of pain ...Aching Tipo de dor ... “dolorida” Tipo de dor: ... “dolorida” (indefinida)
D3/Type of pain…Intermittent “Intermitente” “Intermitente” (que vai e volta)
E3/ Front of the head Região “frontal” “Frente da cabeça”
E3/ Back of the head Região “occipital” “Atrás da cabeça”
E4/ …Throbbing ... “Pulsátil” ... “Latejante”
6 a/... “Aura” ... “Aura” ... “Sensação diferente”
6 a/... Nausea ... “Náusea” ... “Enjoo”
F/... Antihistamine medications ... “Medicamentos anti-histamínicos” ... “Antialérgicos”
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was performed to not jeopardize that item in the ba-
cktranslation, and also to better express missing ter-
ms or those that made no sense in Portuguese. In the 
same question, we added the expression “that comes 
and goes” to the term “intermittent”, and replaced 
the adjective in the expression “dull pressure” by “un-
pleasant” to improve understanding. Backtranslation 
performed by an independent translator showed no 
conceptual difference when compared to the text of 
the English original questionnaire. When assessing 
the equivalence between the backtranslation and 
the English original version of the questionnaire, it 
was evident that only a few items had been altered, 
because the translation suppressed and/or modified 
certain words. Those changes were aimed at pro-
viding semantic equivalence (equivalence between 
words) and idiomatic equivalence (items that nee-
ded to be replaced). For example, expressions of the 
English original questionnaire, such as “do you ex-
perience abdominal pain?” translated and adapted 
to Portuguese as “você tem dor abdominal?” were 
backtranslated as “do you have abdominal pain?”. 
In other words, the term “experience” disappeared 
from the backtranslation because it is not part of 
an usual expression in Portuguese, being suppressed 
already in the phase of translation and adaptation. 
The final version of the questionnaire later applied 
to patients is found in the Appendix.
applicatiOn Of the queStiOnnaire
Ninety-seven adult patients with ADPKD (64 F/33 M; 
35 ± 12 years) were assessed by use of a pain ques-
tionnaire, 57% being Caucasians, 18% afro descen-
dents, 21% mixed heritage, and 2% Asians. Figure 1 
shows the percentage of patients with a family history 
of ADPKD and signs and/or symptoms contributing 
to the diagnosis of ADPKD. The presence of a family 
history of ADPKD was the most contributing factor 
for the diagnosis, and was observed in 55% of the 
patients. Other elements leading to the diagnosis of 
ADPKD were: pain (22%); assessment of hyperten-
sion or hematuria (18%); UTI (6%); and incidental 
findings on periodic tests or medical consultations not 
related to nephrology (9%). The sum of all factors 
reported by patients exceeds 100% (110%), because 
some patients looked for medical assessment due to 
the presence of some symptoms and/or because they 
also had a family history of ADPKD, although they 
did not relate the symptom reported to ADPKD prior 
to the diagnosis.
According to the answers to the pain questionnai-
re, pain at any location was present in 67% (65/97) of 
the patients. Low back pain was more frequent when 
considered in isolation (26%), followed by heada-
che (8%), and abdominal (4%) or chest pains (4%). 
However, patients most commonly reported pain in 
its associated form, as shown in Figure 2, which hi-
ghlights the greater frequency of the association be-
tween low back and/or abdominal pains (52% of the 
reports of pain) and the additional association with 
headache (36% of the reports). Based on the patients’ 
report in the present series, the following percenta-
ge distribution of pain was observed: low back pain, 
77%; abdominal pain, 66%; headache, 15%; and 
chest pain, 4%.
Table 2 shows the clinical and ultrasonographic 
characteristics of the patients who reported isola-
ted low back pain, the association of low back and 
abdominal pains, and the association of low back 
and abdominal pains with headache. Patients wi-
th isolated low back pain had a longer history as 
compared with the group with no pain. The kidney 
volume of patients with isolated low back pain, or 
with the association of abdominal pain and/or hea-
dache was significantly greater than that of patients 
with no pain. A higher percentage of patients with 
Figure 1. Family history, symptoms and/or signs 
leading to the diagnosis of ADPKD.
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Figure 2. Location of the pain (% of patients).
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hypertension and lithiasis was observed in all groups 
with pain. However, even excluding hypertensive pa-
tients from the analysis, the kidney volume of nor-
motensive patients with pain (n = 26) was also sig-
nificantly greater than that of normotensive patients 
with no pain (n = 20), 430 mL vs 315 mL, respecti-
vely (p < 0.036) (data not shown in table). When pa-
tients with lithiasis are excluded, the kidney volume 
of ADPKD patients without lithiasis but with pain 
(n = 41) is significantly greater than that of patients 
without pain (n = 27), 591 mL vs 335 mL, respec-
tively (p < 0.001). As the total number of patients 
reporting isolated abdominal pain (n = 4) or isolated 
headache (n = 8) was small, those patients were not 
included in the statistical analysis. A greater number 
of patients with UTI was observed in the group of 
low back pain associated with abdominal pain, and 
a BMI significantly greater was observed in patients 
with isolated abdominal pain. No statistically sig-
nificant difference was observed in age, number of 
cysts, and loss of renal function between the groups. 
The female sex predominated in the total group of 
pain, especially in that of low back pain.
Figure 3 shows that 46% of the patients with low 
back pain reported its intensity as moderate (scores 
4 - 6). The frequency of low back pain was once a 
week in 39% of the patients (Figure 4). Among pa-
tients with abdominal pain, 42% reported its inten-
sity as moderate (scores 4 - 6) (Figure 5), and 37% as 
less frequently than once a month (Figure 6).
Patients complaining of headache described their 
pain as throbbing (44%), pressure (28%), pounding 
(8%), exploding (5%), and stabbing (3%), occur-
ring once a week in 36% of the cases.
Table 2 clinical and ultraSOnOgraphic characteriSticS 
No pain
(n = 32)
Isolated 
low back pain 
(n = 25)
Low back  +
Abdominal pain
(n = 21)
Headache + 
Abdominal + 
Low back pain
(n = 28)
Age (years) 33 (19 – 63) a 34 (23 – 62) 40 (21 – 61) 38 (20 – 58)
Sex (M/F) 15/17 09/16 03/18 05/23
Age at diagnosis (years) 24 (5 – 58) 28 (6 – 56) 30 (13 – 56) 31 (7 – 45)*
Time of history (years) 3 (0 – 21) 6 (1 – 34)* 5 (1 – 19) 8 (0 – 18)
BMI (kg/m2) 25 (18 – 35) 26 (19 – 36) 25 (19 – 35) 25 (19 – 35)
Hypertension
Lithiasis
12 (37%) b
5(16%)
16 (64%)*
9 (36%)*
16 (76%)*
14 (67%)*
18 (64%)*
0
UTI
Hematuria
CKD 1 / 2
CKD 3
Kidney volume (mL)
Number of cysts
Largest cyst size (cm)
1(3%)
22(69%)
26 (81%)
6 (19%)
361 (180 - 2482)
15 (4 – 15)
3 (2 – 6)
2 ((8%)
2 (8%)
22 (88%)
3 (12%)
646 (251-2150)*
15 (4 – 15)
5 (2 – 8)*
3 (14%)*
6 (29%)
15 (71%)
6 (29%)
657 (216 – 2394)*
15 (4 – 15)
4 (2 – 7)*
0
0 
25 (89%)
03 (11%)
600 (263 – 2870)*
15 (4 – 15)
4 (2 – 11)*
a Median (minimum – maximum); b number (percentage) of patients; *p < 0.05 vs no pain.
Figure 3. Intensity of low back pain.
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Figure 4. Frequency of low back pain.
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dIscussIon
Researchers interested in better assessing and charac-
terizing specific conditions in the health area, but who 
do not have instruments built in their countries and 
languages, can choose to create a new instrument or 
adapt questionnaires already validated in another lan-
guage. Factors such as time and cost for elaborating a 
questionnaire lead most researchers to choose trans-
lation and transcultural adaptation of questionnaires 
already existing in other languages.22,24,29 Guillemin 
et al30 have standardized the process of translation 
and transcultural adaptation into five steps: transla-
tion; review of the translation by a multidisciplinary 
committee; translation into the original language (ba-
cktranslation); pre-test to assess cultural equivalence; 
and assessment of the need to attribute weight to the 
scores. However, the simplification of that method 
has already been suggested by Da Mota-Falcão et al,31 
who have reported that even simplified questionnai-
res still satisfy the objectives proposed.
Pain has been reported as a very frequent symptom 
of ADPKD patients, affecting up to 60% of them15,32 
and jeopardizing their quality of life.33 Because that 
symptom involves a series of sensorial qualities and 
subjective aspects,22,32 it requires a careful investi-
gation by a multiprofessional team. Duarte et al23 
have emphasized the importance of using proper 
instruments to assess the situations and experiences 
in the health area, so that reliable information is ob-
tained. Despite the existence of some pain questio-
nnaires translated and validated in Brazil,22,34 none 
of them has the necessary and/or adequate specifi-
cations to assess pain in ADPKD. Thus, this study 
aimed at performing a translation and transcultural 
adaptation of an English pain questionnaire, already 
validated to be used in ADPKD patients.16 That va-
lidated pain questionnaire is currently being used in 
the HALT PKD study.35 A simplified version of the 
method developed by Guillemin30 was adopted, since 
the questionnaire to be used in our study approa-
ched simple questions, which did not require weight 
attributions, using only scores of pain intensity of 
the visual analogue scale (VAS).16,28
The modification of the title of the pain question-
naire adopted in this study to “Questionnaire for pa-
tients with polycystic kidney disease”, suppressing the 
subtitle of the English original version containing the 
terms “pain” and “headache”, and the simplification 
of the terminology aimed at neither inducing patients 
to report non-existing pains nor overestimating the 
value of existing pains. In addition, in our opinion, 
our decision not to include patients with pain on the 
occasion of completing the questionnaire contributes 
to legitimate the results, a preoccupation not expres-
sed by the authors of the English original version, but 
which we consider important.
The comparison of the initial translation and that 
suggested by the multidisciplinary team provided 
equivalence and reconciliation between most items. In 
the phase of transcultural adaptation, the use of more 
simple expressions or synonyms, in addition to the 
suppression of words in the backtranslation, has alre-
ady occurred in other studies of translation and trans-
cultural adaptation performed in Brazil,22,24 without 
jeopardizing the final result of the study. Differently 
from the English original questionnaire that was self-
-applied,16 in our study, the questionnaire was ap-
plied during the pre-consultation, so that the greatest 
amount of information could be obtained from the 
patient, in addition to preventing and minimizing the 
number of non-responders usually found with self-
-applied questionnaires. However, the questionnaire 
proved to be of rapid and easy application, and can 
be self-applied in the future.
By applying the questionnaire in our ADPKD 
sample, 67% (65/97) of the patients assessed could 
be identified as having some type of pain, a preva-
lence similar to that reported in the literature, which 
is around 60%.6,15,22,32 The use of that questionnai-
re has also evidenced that the presence of a family 
Figure 5. Intensity of abdominal pain.
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Figure 6. Frequency of abdominal pain.
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history of ADPKD was the finding that most frequen-
tly led to the diagnosis of ADPKD (55% of the ca-
ses). However, low back pain was the symptom most 
frequently reported by the patients (13%), and, when 
added to abdominal pain, it reached 22% of the pa-
tients, confirming that pain can contribute to the 
diagnosis of ADPKD.16 In addition, it is worth noting 
that of the patients who sought a specialist due to a 
positive family history, 21% reported pain before the 
diagnosis, but had not related it to polycystic kidney 
disease, in accordance with that reported by Bajwa et 
al.16 Low back and abdominal pains were the most 
frequent ones, followed by headache and chest pain, 
as reported by Bajwa et al.16 and, in Brazil, by Romão 
et al.36 The present study evidenced that those pains 
(low back, abdominal, and headache) were reported 
in isolation or, more frequently, in association, which 
is also in accordance with the study by Bajwa et al,16 
in which 70% of the patients had more than one type 
of pain, and in only 18% the pain had a single loca-
tion. The frequencies of low back (once a week) and 
abdominal (less than once a month) pains found in 
our study differed from those of the North-American 
population, which characterized those pains as conti-
nuous. The intensity of the low back/abdominal pains 
was similar to that in the literature.16 The reasons 
why the patients reported a lower recurrence of the 
episodes of low back/abdominal pain in the present 
series are not clear, but that finding may be attribu-
ted to a shorter time interval between the diagnosis 
of ADPKD and the application of the questionnaire, 
which was six years, while in the study by Bajwa et 
al16 that interval was around 16 years. In addition, as 
the English original questionnaire was self-applied, it 
may have caused an overestimation of the frequency 
of pains that can or cannot be related to polycystic 
kidney disease.
In the present study, the female sex predominated 
among patients reporting pain in general. In the study 
by Bajwa et al,16 the number of women in the total 
sample was also greater. However, because of the cha-
racteristics of the present instrument, the greater re-
port of pain in women could represent a bias of pains 
originating from the female genital tract not related 
to ADPKD.
Regarding the clinical manifestations and labora-
tory alterations and their associations with the pre-
sence of pain, the present sample showed a greater 
percentage of hypertensive patients with associated 
nephrolithiasis in the groups of patients with pain, 
especially low back and/or abdominal pain. Although 
UTI episodes were slightly more frequent in the total 
group with pain, the number of confirmations with 
urine cultures on medical records was small, thus, 
hindering the relevance of that finding. Surprisingly, 
microscopic hematuria did not differ between the 
groups with and without pain. As hematuria is usu-
ally related to the rupture of cysts,1,37 the urine sedi-
ment exams reported on the medical records, required 
on a routine basis and not during an episode of pain, 
may explain the lack of a temporal relation between 
hematuria and the episodes of pain in our study. As 
low back pain could be related to excessive weight, 
we also assessed the relation between the presence of 
pain and BMI. That association, however, has not be-
en detected.
Although the median age of patients with isolated 
or associated low back pain and that of patients with 
no pain did not differ, the median age at the diag-
nosis of ADPKD tended to be greater in the groups 
with low back and abdominal pains (associated or 
not with headache), despite the lack of statistical sig-
nificance. The estimated time of history (from diag-
nosis to application of the questionnaire) was longer 
in patients with pain, but statistical significance was 
reached only by those with isolated low back pain. 
Still, in accordance with data reported by Bajwa et 
al,16 the pain in the present sample appeared early in 
the course of ADPKD, when approximately 80% of 
the patients still had normal renal function. Thus, no 
association was observed between pain and alteration 
in renal function, emphasizing that pain is not a late 
manifestation in the course of ADPKD, as already re-
ported by other authors.16
The progressive increase in kidney volume do-
es not associate only with the deterioration of renal 
function in ADPKD,26,38 but also with the presence 
of hypertension39 and nephrolithiasis, as previously 
reported by Nishiura et al 10 at our service, and possi-
bly with the appearance of pain. In our series, the pa-
tients with isolated low back and/or abdominal pain 
(or associated with headache) had a kidney volume 
significantly greater than that in the group with no 
pain. The size of the largest cyst was also significan-
tly greater in patients with those types of pains. The 
fact that the number of patients with hypertension 
and lithiasis is greater in the groups with pain could 
represent a bias in the conclusions about kidney volu-
me. However, as previously mentioned, when patients 
with hypertension and lithiasis were excluded from 
the analysis (see Results), the differences in kidney 
volume between the groups with and without pain 
persisted in normotensive patients with ADPKD and 
no lithiasis associated.
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In conclusion, the results of this study emphasize 
the importance of the use of a specific instrument to 
assess pain in patients with ADPKD. The pain ques-
tionnaire revealed that pain, in addition to being a 
very frequent and early symptom in the course of 
ADPKD, can help in the early diagnosis of that disea-
se. The use of that tool has allowed a better characte-
rization of pain location, intensity, and frequency, in 
addition to the assessment of the association of pain 
with other clinical, laboratory, and imaging manifes-
tations in ADPKD. A greater frequency of low back 
and/or abdominal pains and its significant association 
with the increase in kidney volume has been observed. 
Thus, we believe that the use of a specific pain ques-
tionnaire for assessing ADPKD patients will draw 
attention to the pain complaints of that population, 
contributing to the follow-up and control of their as-
sociated complications.
DATE OF COMPLETION _____/_____/____
Name :
___________________________________________________________________________
Address:
___________________________________________________________________________
Age: _____     Sex: M [  ] F [  ]             Birth date: __/__ /__
Race: Black [  ] Caucasian [ ] Asian [  ] Other [  ]
1. Year you were first aware that you had polycystic kidney disease (PKD): __________
2. Age at diagnosis: ______
3. What led to the diagnosis? (please explain)
•	Finding during evaluation of another problem [  ]
•	Routine evaluation done because of family history of  polycystic kidneys [  ]
•	Symptoms led to a physician ordering exams [  ]
•	Abdominal pain [  ]
•	Low back pain [  ]
•	Blood in the urine [ ]
•	Other [ ] Please, explain:
  ________________________________________________________________________
4. Do you know of any blood relatives who have polycystic kidneys: Y [  ] N [  ]
5. If yes, please list with relationship and age of relative at the time of diagnosis of polycystic kidneys: 
Age Relationship
APPendIX: QuestIonnAIre for PAtIents wIth PolycystIc kIdney dIseAse 
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Age at time of test Results reported to you
Abdominal ultrasound
Intravenous pyelogram
Abdominal CT scan
Cerebral CT scan
Abdominal MRI
Cerebral MRI
6. Which diagnostic tests have you had for polycystic kidneys? Please, list the results:
7. Did you experience abdominal or low back pain before the diagnosis of polycystic kidneys? Y [  ]  N [  ]
8. How was that pain treated before the diagnosis of polycystic kidneys?
9. Since the diagnosis of polycystic kidneys, have you experienced persistent or chronic pain in the 
following locations?
Mark with an X, Yes or No:
Head – Y [  ] N [  ] Chest - Y [  ] N [ ]
Back – Y [  ] N [  ] Abdomen Y [  ] N [  ]
Legs – Y [  ] N [  ]
10. Did you ever think that those pains were related to polycystic kidneys? Y [  ] N [  ]
11. Has that pain ever been associated with blood in your urine? Y [  ] No [  ]
Section A – Abdominal pain
1. Do you experience abdominal pain? Y [  ] N [  ]
If your answer is yes, please mark the location on Chart 1 (front and back) on the last page and complete 
this section. If your answer is no, please skip to Section B.
2. How often?
[  ] always
[  ] at least once a day
[  ] about once a week
[  ] about once a month
[  ] less than once a month
3. Can you rate this pain on average by placing an X on the following scale:
(no pain) 0 1 2 3 4 5 6 7 8 9 10 (worst pain possible)
4. Have you had any of the following treatments for this pain? 
Mark with an X, Yes [  ] or No [  ]
a) surgery: Y [  ] N [  ]
b) analgesics  Y [  ] N [  ] 
If yes, please name:_______________________________
c) ice Y [  ] N [ ] 
d) heat Y [  ] No [  ]
e) others (please specify): _____________________________________________________________________
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5. Do you experience stomach fullness? Y [  ] No [  ]
6. Do you feel full after eating a small amount of food? Y [  ] N [  ]
7. Is your appetite poor? Y [  ] No [  ]
8. Is your appetite poor because of stomach fullness? Y [  ] N [  ]
9. Is your appetite poor because of nausea? Y [  ] N [  ]
Section B – Back pain
1. Do you experience low back pain? Y [ ] N [ ]
If your answer is yes, please mark the location of pain on Chart 1 attached and complete this section. 
If your answer is no, please skip to Section C.
2. How often?
[  ] always
[  ] at least once a day
[  ] about once a week
[  ] about once a month
[  ] less than once a month
Section C – Back pain shooting to the hips or legs
1. Do you experience back pain shooting down to your hips or legs? Y [  ] N [  ]
If yes, please mark the location on Chart 1 attached and complete this section. If no, skip to Section D.
2. How often?
[  ] always
[  ] at least once a day
[  ] about once a week
[  ] about once a month
[  ] less than once a month
3. Can you rate this pain on average by placing an X on the following scale:
(no pain) 0 1 2 3 4 5 6 7 8 9 10 (worst pain possible)
4. Have you had any of the following treatments for this pain?
a) surgery   Y [  ] N [  ]
b) analgesics   Y [  ] N [  ] 
If yes, please name: _________________________
c) ice Y [  ] N [  ]
d) heat Y [  ] N [  ]
e) others (please specify): _____________________________________________________________________
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Section D – Chest pain
1. Do you experience chest pain? Yes [  ] No [  ]
If your answer is yes, please mark the location of pain on Chart 1 attached and complete this section. 
If your answer is no, skip to Section E.
2. How often?
[  ] always
[  ] at least once a day
[  ] about once a week
[  ] about once a month
[  ] less than once a month
3. Can you rate this pain on average by placing an X on the following scale:
(no pain) 0 1 2 3 4 5 6 7 8 9 10 (worst pain possible)
Type of pain:
[  ] stabbing
[  ] dull pressure
[  ] cramping
[  ] aching (undefined)
[  ] intermittent (that comes and goes)
[  ] continuous
4. Have you had any of the following treatments for this pain?
a) surgery   Y [  ] N [  ]
b) analgesics   Y [  ] N [  ] If yes, please name:____________________________
c) ice Y [  ] N [  ]
d) heat Y [  ] N [  ]
e) others (please specify):________________________________________________
Section E - Headache
1. Do you experience chronic headache? Y [  ] N [  ]
2. How often?
a) daily
b) once a week
c) 5 – 10 per month
d) once a month
e) rarely
3. My headache affects:
a) one side of the head
b) both sides of the head
c) front of the head
d) back of the head
e) the whole head
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4. My headache feels like:
a) throbbing
b) pounding
c) pressure
d) stabbing
e) exploding 
f) other (please, specify):______________________________________________________________________
5. Have you ever experienced a very strong headache? Y [ ] No [ ]
If the answer is yes, how was it treated? Please, describe:__________________________________________
6. Is your headache:
a) preceded by an “aura” (different sensation): Y [  ] N [  ]
b) associated with nausea: Y [  ] N [  ]
c) associated with vomiting: Y [  ] N [  ]
7. Have you ever had a CT or MRI of your head? Y [  ] N [  ]
If yes, result: _______________________________________________________________________________
8. Do you suffer from migraine? Y [  ] N [  ]
Who diagnosed the migraine? ________________________________________________________________
9. Timing – at what time of the day?
a) morning
b) afternoon
c) evening
d) night
10. Have you or a family member ever been diagnosed with a brain hemorrhage?
Y [  ] N [  ]
If yes, please explain: _________________________________________________________________________
Section F – List antiallergic medications that you take: ____________________________________________
Section G - List medications for high blood pressure that you take: _________________________________
Section H - List other current medications: ______________________________________________________
Section I – List any other treatment for polycystic kidneys: _________________________________________
Section J – Do you suffer from any other medical problem? If yes, please list: _________________________
____________________________________________________________________________________________
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Figure 1. Questionnaire for patients with polycystic kidneys.
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